CYCC
Price
$0.32
Change
-$0.01 (-3.03%)
Updated
Jul 1, 11:26 AM (EDT)
Capitalization
7.75M
MTVA
Price
$0.64
Change
-$0.00 (-0.00%)
Updated
Jul 1, 11:35 AM (EDT)
Capitalization
12.6M
Interact to see
Advertisement

CYCC vs MTVA

Header iconCYCC vs MTVA Comparison
Open Charts CYCC vs MTVABanner chart's image
Cyclacel Pharmaceuticals
Price$0.32
Change-$0.01 (-3.03%)
Volume$100
Capitalization7.75M
MetaVia
Price$0.64
Change-$0.00 (-0.00%)
Volume$1K
Capitalization12.6M
CYCC vs MTVA Comparison Chart in %
Loading...
CYCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYCC vs. MTVA commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYCC is a Buy and MTVA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (CYCC: $0.33 vs. MTVA: $0.64)
Brand notoriety: CYCC and MTVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYCC: 21% vs. MTVA: 23%
Market capitalization -- CYCC: $7.75M vs. MTVA: $12.6M
CYCC [@Biotechnology] is valued at $7.75M. MTVA’s [@Biotechnology] market capitalization is $12.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYCC’s FA Score shows that 0 FA rating(s) are green whileMTVA’s FA Score has 0 green FA rating(s).

  • CYCC’s FA Score: 0 green, 5 red.
  • MTVA’s FA Score: 0 green, 5 red.
According to our system of comparison, MTVA is a better buy in the long-term than CYCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYCC’s TA Score shows that 5 TA indicator(s) are bullish while MTVA’s TA Score has 2 bullish TA indicator(s).

  • CYCC’s TA Score: 5 bullish, 3 bearish.
  • MTVA’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, CYCC is a better buy in the short-term than MTVA.

Price Growth

CYCC (@Biotechnology) experienced а +0.95% price change this week, while MTVA (@Biotechnology) price change was -4.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.03%. For the same industry, the average monthly price growth was +32.19%, and the average quarterly price growth was +3.52%.

Industries' Descriptions

@Biotechnology (-1.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MTVA($12.6M) has a higher market cap than CYCC($7.75M). MTVA YTD gains are higher at: -68.315 vs. CYCC (-94.510). CYCC has higher annual earnings (EBITDA): -12.68M vs. MTVA (-25.79M). MTVA has more cash in the bank: 11.2M vs. CYCC (3.45M). CYCC has less debt than MTVA: CYCC (9K) vs MTVA (118K). CYCC has higher revenues than MTVA: CYCC (14K) vs MTVA (0).
CYCCMTVACYCC / MTVA
Capitalization7.75M12.6M61%
EBITDA-12.68M-25.79M49%
Gain YTD-94.510-68.315138%
P/E Ratio0.11N/A-
Revenue14K0-
Total Cash3.45M11.2M31%
Total Debt9K118K8%
FUNDAMENTALS RATINGS
CYCC vs MTVA: Fundamental Ratings
CYCC
MTVA
OUTLOOK RATING
1..100
372
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9996
P/E GROWTH RATING
1..100
10063
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MTVA's Valuation (55) in the null industry is in the same range as CYCC (65) in the Biotechnology industry. This means that MTVA’s stock grew similarly to CYCC’s over the last 12 months.

MTVA's Profit vs Risk Rating (100) in the null industry is in the same range as CYCC (100) in the Biotechnology industry. This means that MTVA’s stock grew similarly to CYCC’s over the last 12 months.

MTVA's SMR Rating (100) in the null industry is in the same range as CYCC (100) in the Biotechnology industry. This means that MTVA’s stock grew similarly to CYCC’s over the last 12 months.

MTVA's Price Growth Rating (96) in the null industry is in the same range as CYCC (99) in the Biotechnology industry. This means that MTVA’s stock grew similarly to CYCC’s over the last 12 months.

MTVA's P/E Growth Rating (63) in the null industry is somewhat better than the same rating for CYCC (100) in the Biotechnology industry. This means that MTVA’s stock grew somewhat faster than CYCC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYCCMTVA
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 19 days ago
83%
Bullish Trend 6 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CYCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UPXI2.980.39
+15.28%
Upexi Inc
LAKE13.610.43
+3.26%
Lakeland Industries
ILMN95.410.62
+0.65%
Illumina
AROC24.83-0.17
-0.68%
Archrock
ARKO4.23-0.13
-2.98%
ARKO Corp

CYCC and

Correlation & Price change

A.I.dvisor tells us that CYCC and MTVA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYCC and MTVA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCC
1D Price
Change %
CYCC100%
-0.21%
MTVA - CYCC
26%
Poorly correlated
+2.10%
HOWL - CYCC
24%
Poorly correlated
+6.86%
PRQR - CYCC
22%
Poorly correlated
N/A
LEXX - CYCC
22%
Poorly correlated
+2.47%
CBUS - CYCC
21%
Poorly correlated
-2.13%
More

MTVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTVA has been loosely correlated with ETXPF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MTVA jumps, then ETXPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTVA
1D Price
Change %
MTVA100%
+2.10%
ETXPF - MTVA
51%
Loosely correlated
N/A
HOOK - MTVA
44%
Loosely correlated
+0.40%
LQDA - MTVA
44%
Loosely correlated
-4.89%
ARGX - MTVA
43%
Loosely correlated
-1.59%
BLUE - MTVA
37%
Loosely correlated
N/A
More